FDA’s recent IRB guidance more style than substance
By Lee Seabrooke, HSD, PhD student
The guidance provides useful operational issues to consider, such as the identification of “those studies for which IRB oversight is being transferred” and the establishment of “an effective date for transfer of oversight, including…
Read More »